Skip to content

Comparing The Effectiveness Of Combined Use Of Fluids And The Drug Norepinephrine Versus Sequential Use Of Fluids Followed By The Drug Norepinephrine Therapy In Treating Septic Shock: A Randomised Clinical Trial

Comparing Shock Control Rates Of Combined Versus Sequential Fluids And Norepinephrine Therapy In Septic Shock : A Randomised Open Label Trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082807
Enrollment
120
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Fluids plus norepinephrine: I.V Norepinephrine 0.05 microgram/kg/min along with the normal or ringer lactate (upto 30ml/kg) till hemodynamic goal of mean arterial pressure of more than

Sponsors

All India Institute Of Medical Sciences, New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Adults aged more than or equal to 18 years presenting to the emergency room with hypotension determined by mean arterial blood pressure lower than 65 mm Hg 2)Patients with features of suspected or confirmed sepsis 3)Patients with serum lactate more than 2 mmol/L 4)Patients with the Modified Early Warning Score (MEWS) more than or equal to 5 5)Legally authorised representative willing to give valid consent

Exclusion criteria

Exclusion criteria: 1)Patients aged less than 18 years on the day of admission. 2)Patients administered more than 3 L of IV fluids before enrollment 3)Pregnancy or Lactation: Pregnant or breastfeeding women are excluded due to potential risks to the fetus or infant 4)Known allergy or hypersensitivity to norepinephrine 5)Known contraindications to aggressive fluid resuscitation such as heart failure with reduced ejection fraction or severe pulmonary edema

Design outcomes

Primary

MeasureTime frame
To compare shock control rate at 6 hours from the time of randomization between intervention group and control groupTimepoint: Shock control rate at 6 hours from the time of randomization which is determined by sustained mean arterial pressure of more than or equal to 65mm Hg, together with evidence of adequate tissue perfusion.

Secondary

MeasureTime frame
To compare requirement of mechanical ventilator support in intervention group & control group within six hoursTimepoint: Within 6 hours from the time of randomization;To compare mortality upto 7 days and 28 days in both the groupsTimepoint: Upto 7 days and 28 days from the time of randomization;Documenting & comparing any adverse events such as extravasation of norepinephrine, new onset arrhythmias, acute intestinal ischemia, peripheral ischemia within 6 hours in both intervention group & control groupTimepoint: Within 6 hours from the time of randomization

Countries

India

Contacts

Public ContactDr KAPIL DEV SONI

All India Institute Of Medical Sciences, New Delhi

kdsoni111@gmail.com9718661658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026